SGK1 and Parkinson disease: On the other hand, the mDA neurons in the SNs of MPTP‐PD mice treated with the SGK1 inhibitor looked much healthier, with larger cell bodies and longer neurite outgrowths (Fig 7E enlarged images 3–4, G and H).